|
|
|
|
|||||
| Accession | Disease | Description | Year | Source | RNA-Seq | Count | Biomarkers |
| GSE115513 | Colon Cancer | miRNA and colorectal cancer: associations with tumor phenotype and survival | 2018 | Tissue | N | 1513 |
|
| GSE81981 | Colon Cancer | Expression data from early stage CRC patients' tumors [Agilent] | 2016 | Tissue | N | 148 |
|
| GSE18392 | Colon Cancer | Genome-wide analysis of miRNA levels in colon cancer | 2009 | Tissue | N | 145 |
|
| GSE32273 | Ulcerative Colitis | Genome-wide maps of circulating miRNA biomarkers for Ulcerative Colitis | 2011 | Blood | N | 132 |
|
| GSE48267 | Colon Cancer | Differential Expression of miRNAs: Implication in Colon Cancer Racial Health Disparity | 2013 | Tissue | N | 122 |
|
| GSE48267 | Colon Cancer | Differential Expression of miRNAs: Implication in Colon Cancer Racial Health Disparity | 2013 | Tissue | N | 122 |
|
| GSE41655 | Colon Cancer | MicroRNA expression profiling of colorectal normal mucosa, adenoma and adenocarcinoma tissues | 2012 | Mucus | N | 107 |
|
| GSE56350 | Colon Cancer | MicroRNA profiles discriminate among colon cancer metastasis | 2014 | Tissue | N | 104 |
|
| GSE25609 | Colon Cancer | Plasma microRNA profiling by microarray elucidates several candidate biomarkers for colorectal cancer screening | 2010 | Blood | N | 77 |
|
| GSE112955 | Colon Cancer | Circulating microRNA of advanced colorectal cancer patients | 2018 | Plasma | N | 75 |
|
| GSE68306 | Ulcerative Colitis | miR-193a-3p is a key tumor-suppressor in ulcerative colitis-associated colon cancer and promotes carcinogenesis through regulation of IL17RD. | 2015 | Tissue | Y | 45 |
|